Patients with the most aggressive form of prostate cancer who have surgery - radical prostatectomy - were found to have a 10-year cancer-specific survival rate of 92%, which is high, and a 77% overall survival rate, according to researchers from the Fox Chase Cancer Center and the Mayo Clinic...
As hundreds of prostate cancer researchers, advocates and supporters Advance on Washington this week and push for more progress in fighting the disease, the Prostate Cancer Foundation applauds the prostate cancer legislation introduced on Tuesday by Senator Jon Tester of Montana. "Just...
In a presentation at the Congressional Black Caucus Foundation's Annual Legislative Conference Health Braintrust meeting, Faina Shtern, M.D., president and CEO of AdMeTech Foundation, unveiled overwhelming support from Congressional Black Caucus (CBC) members and patient advocacy organizations...
Researchers have found that according to existing evidence from randomized controlled trials, routinely screening large populations of men for prostate cancer is not recommended. Their report appears in today's issue of the BMJ (British Medical Journal). Another study published today in the same...
Ed Randall's Fans For The Cure charity is launching its first ever BLUETEMBER program with special events at cities around the country to coincide with National Prostate Cancer Awareness Month. BLUETEMBER events included a free PSA screening during the ORIOLES-YANKEES game at Yankee Stadium on...
Members of the Prostate Cancer Roundtable, consisting of America's Leading Prostate Cancer Organizations, are asking President Obama to place a blue ribbon on the White House and light the White House blue in the evenings in recognition of Prostate Cancer Awareness Month in September. This...
Prostate cancer (PrCa) cells form differentiated spheroids or "prostaspheres" in three-dimensional cell culture (3D culture) when embedded in extracellular matrix such as MatrigelTM, rat tail collagen, or hydrogel. While this has been pioneered and explored widely, e.g. in breast cancer, the...
UroToday.com - In the online edition of the International Journal of Cancer, Dr. Ali Murad and colleagues report that non-steroidal anti-inflammatory drugs (NSAIDs) do not decrease the risk of PSA-detected prostate cancer (CaP). The premises for the study are reports that cyclooxygenase-2 is an...
UroToday.com - Endocrine treatment (ET), which interrupts testosterone regulation of the prostate tumor, is the cornerstone treatment for men with locally advanced or metastatic prostate cancer. A number of metabolic side-effects have been reported including increased body weight, insulin...
UroToday.com - External beam radiotherapy (EBRT) is a well-established curative treatment for localized prostate cancer. Acute and late toxicity rates after EBRT can be considerable and have been the subject of many studies. Dose-volume effect relationships have been described extensively. In...
With a new study showing the PSA test reduces the prostate cancer death rate by 44 percent, ZERO The Project to End Prostate Cancer demands an apology for all at risk of the disease from the American Cancer Society, which has long discounted the importance of prostate cancer testing. "It's time...
A new study from Sweden revealed that screening men between 50 and 65 years old with the PSA test for prostate cancer reduced deaths by nearly a half over 14 years and concluded that prostate cancer screening compares favorably with screening for other cancers, but also cautioned that the risk...
Akash Patnaik, MD, PhD, a physician-scientist in the Hematology/Oncology Divison at Beth Israel Deaconess Medical Center (BIDMC) and Instructor of Medicine at Harvard Medical School has received a Young Investigator Award from The Prostate Cancer Foundation (PCF). The three-year $225,000 award...
UroToday.com - Although several studies have reported a dose-response in permanent seed prostate brachytherapy implants, we were unable to find a dose-response in our patient population or a detailed case-control radiobiological analysis.(1, 2) In our latest attempt,(3) we updated the post...
UroToday.com - Using linked SEER-Medicare data from 2003-2005, we found no evidence of a difference in postoperative or genitourinary complications (including the need for incontinence procedures) or need for additional cancer treatment between patients undergoing open versus minimally-invasive...
In what could lead to a major advance in the treatment of prostate cancer, scientists now know exactly why polyphenols in red wine and green tea inhibit cancer growth. This new discovery, published online in The FASEB Journal, explains how antioxidants in red wine and green tea produce a...
Molecular imaging has a powerful new weapon in the fight against prostate cancer. Research introduced at SNM's 57th Annual Meeting demonstrates how a novel peptide-targeted imaging agent could help clinicians detect a biological process that signals cancer in prostate cells. Information gathered...
Does population-based prostate cancer testing actually save lives and, if so, how many men need to be tested in order to save one life? These questions were addressed by top prostate cancer experts at the 105th Annual Scientific Meeting of the American Urological Association (AUA)...
More...
Men who refuse surgery for prostate cancer and instead opt for "watchful waiting" - monitoring cancer progression without undergoing treatment - have a significantly worse long-term survival rate than those patients that choose radiotherapy, according to researchers at Henry Ford Hospital in...